MedPath

Olive oil

Generic Name
Olive oil
Brand Names
Clinoleic, Clinolipid, Olimel, Periolimel
Drug Type
Biotech
CAS Number
8001-25-0
Unique Ingredient Identifier
6UYK2W1W1E

Overview

Oil extracted from olives . Consists primarily of the glycerides of the fatty acids linoleic, oleic and palmitic. Used as a source of fatty acids in total parenteral nutrition and as an additive in some cosmetic products .

Indication

For use in adults as a source of calories and fatty acids in total parenteral nutrition . Sometimes used as an additive in cosmetic products.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2020/09/18
Phase 4
Completed
2020/06/04
Phase 2
Active, not recruiting
2019/08/09
Phase 1
UNKNOWN
2017/05/11
Phase 4
Completed
General University Hospital, Prague
2016/05/03
Phase 3
Completed
Carola Pfeiffer-Mosesson
2015/06/22
Phase 4
Terminated
2014/07/10
Phase 2
Completed
2013/12/12
Phase 3
Completed
2013/09/17
Phase 4
Completed
Johane Allard
2013/05/10
Phase 4
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Fresenius Kabi USA, LLC
63323-820
INTRAVENOUS
5 g in 100 mL
8/30/2019
Baxter Healthcare Corporation
0338-9540
INTRAVENOUS
16 g in 100 mL
7/20/2016
BIOCARE PLUS INTERNATIONAL LIMITED
85522-001
TOPICAL
0.47 g in 1 g
4/9/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
SMOFKABIVEN EXTRA NITROGEN EMULSION FOR INFUSION
SIN16135P
INJECTION, EMULSION
7.2g/1000ml
3/24/2021
SmofKabiven Emulsion for Infusion
SIN14286P
INJECTION, EMULSION
50g /1000ml
1/8/2013
SmofKabiven Electrolyte Free Emulsion for Infusion
SIN14292P
INJECTION, EMULSION
50g /1000ml
1/16/2013
SmofKabiven Peripheral Emulsion for Infusion
SIN14287P
INJECTION, EMULSION
50g /1000ml
1/8/2013
SMOFlipid 20%
SIN13246P
INJECTION, EMULSION
50g per 1000ml
4/12/2007
SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE-FREE EMULSION FOR INFUSION
SIN16136P
INJECTION, EMULSION
7.2g/1000ml
3/24/2021

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
OLIMEL N9E EMULSION FOR INFUSION
N/A
N/A
N/A
10/24/2013

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 mL
180546
Medicine
A
1/9/2012
OLICLINOMEL N4-550 E 1000 mL IV emulsion for infusion with electrolytes bag
136599
Medicine
A
9/4/2007
OLICLINOMEL N4-550 E 2500 mL IV emulsion for infusion with electrolytes bag
141396
Medicine
A
9/4/2007
OLIMEL N5-860E Emulsion for intravenous infusion
197417
Medicine
A
8/9/2013
Olimel N12-640 emulsion for intravenous infusion bag.
303755
Medicine
A
7/1/2019
Zinzino BalanceOil+ Orange Lemon Mint Flavour
380401
Medicine
A
12/8/2021
SMOFKABIVEN LOW OSMO amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 2500 mL biofine bag
329619
Medicine
A
8/27/2020
SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 2463 mL
180550
Medicine
A
1/9/2012
SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 986 mL
173891
Medicine
A
1/9/2012
SMOFKABIVEN LOW OSMO amino acids 2.5%, electrolytes 0.4%, lipids 3.5% & glucose 6.8% emulsion for intravenous infusion 1400 mL biofine bag
329617
Medicine
A
8/27/2020

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.